Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

PRTC

PureTech Health (PRTC)

PureTech Health PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRTC
DateTimeSourceHeadlineSymbolCompany
26/03/202123:07Business WirePureTech Founded Entity Akili Announces the Results of EndeavorRx™ Clinical Study in Pediatric ADHD Published in Nature Dig...NASDAQ:PRTCPureTech Health PLC
18/03/202121:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
18/03/202118:00Business WirePureTech Announces Board Member RetirementNASDAQ:PRTCPureTech Health PLC
15/03/202121:29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
15/03/202118:00Business WirePureTech: Notice of ResultsNASDAQ:PRTCPureTech Health PLC
03/03/202123:00Business WirePureTech to Present at The Barclays Global Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
02/03/202123:55Business WirePureTech Founded Entity Karuna Therapeutics Announces Pricing of Public Offering of Common StockNASDAQ:PRTCPureTech Health PLC
02/03/202123:00Business WireVedanta Biosciences to Present at Upcoming Investor ConferencesNASDAQ:PRTCPureTech Health PLC
26/02/202101:17Business WirePureTech Announces Publication of Glyph™ Platform Preclinical Proof-of-Concept Study in Journal of Controlled ReleaseNASDAQ:PRTCPureTech Health PLC
25/02/202118:00Business WirePureTech Founded Entity Karuna Therapeutics Announces New England Journal of Medicine Publication of Data from EMERGENT-1 Pha...NASDAQ:PRTCPureTech Health PLC
18/02/202123:00Business WirePureTech to Present at The SVB Leerink 10th Annual Global Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
17/02/202107:53Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PRTCPureTech Health PLC
10/02/202122:08Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
10/02/202118:00Business WirePureTech Founded Entity Vor Biopharma Closes Over $200M Initial Public OfferingNASDAQ:PRTCPureTech Health PLC
10/02/202118:00Business WirePureTech Receives Approximately $118 Million from Sale of Portion of Founded Entity SharesNASDAQ:PRTCPureTech Health PLC
08/02/202123:00Business WirePureTech Founded Entity Vedanta Biosciences Appoints Mark Mullikin as Chief Financial OfficerNASDAQ:PRTCPureTech Health PLC
08/02/202123:00Business WireVedanta Biosciences Appoints Mark Mullikin as Chief Financial OfficerNASDAQ:PRTCPureTech Health PLC
05/02/202123:22Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRTCPureTech Health PLC
05/02/202122:50Business WirePureTech Founded Entity Vor Biopharma Announces Pricing of Initial Public OfferingNASDAQ:PRTCPureTech Health PLC
29/01/202118:00Business WirePureTech Adds Bharatt Chowrira, PureTech’s President and Chief of Business and Strategy, to Board of DirectorsNASDAQ:PRTCPureTech Health PLC
14/01/202123:05Business WirePureTech Founded Entity Vor Announces FDA Clearance of IND Application for VOR33NASDAQ:PRTCPureTech Health PLC
14/01/202122:50Business WirePureTech Founded Entity Follica Adds Two Leaders in Aesthetic Medicine and Dermatology to its Board of DirectorsNASDAQ:PRTCPureTech Health PLC
14/01/202122:50Business WireFollica Adds Two Leaders in Aesthetic Medicine and Dermatology to Its Board of DirectorsNASDAQ:PRTCPureTech Health PLC
12/01/202122:50Business WireVedanta Biosciences Announces $25 Million Investment from Pfizer Inc.NASDAQ:PRTCPureTech Health PLC
12/01/202122:50Business WirePureTech Founded Entity Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.NASDAQ:PRTCPureTech Health PLC
05/01/202118:00Business WirePureTech Announces the Appointment of George Farmer, Ph.D., as Chief Financial OfficerNASDAQ:PRTCPureTech Health PLC
21/12/202023:00Business WirePureTech to Present at 38th Annual J.P. Morgan Healthcare Conference and Other ConferencesNASDAQ:PRTCPureTech Health PLC
11/12/202023:00Business WirePureTech Advances Wholly Owned Candidate LYT-200 into Phase 1 Trial for Potential Treatment of Metastatic Solid TumorsNASDAQ:PRTCPureTech Health PLC
10/12/202023:00Business WirePureTech Initiates Phase 2a trial of LYT-100 (Deupirfenidone) in LymphedemaNASDAQ:PRTCPureTech Health PLC
10/12/202005:42Business WireFollica Announces Pilot Study for Female Pattern Hair Loss Published in International Journal of Women’s DermatologyNASDAQ:PRTCPureTech Health PLC
 Showing the most relevant articles for your search:NASDAQ:PRTC